As 1 Roche Investor Suit Ends, Another Moves Ahead
Though Roche Holdings Inc. satiated one group of shareholders when it upped its offer to $95 a share for Genentech Inc., other investors are pushing ahead with a lawsuit that accuses...To view the full article, register now.
Already a subscriber? Click here to view full article